... diagnosis, but what do you think?

No, great, great point, and I think the fact is we are seeing it everywhere, right? Workplace, socially, we're seeing people's faces change quite s- significantly.

And no, Ozempic face isn't the medical diagnosis.

But we, we generally refer to it as lipoatrophy.

So we're seeing the facial shape and structure change considerably because of the changing in what we call fat pads that normally sit in our skin and, or under our skin, and the, the most well-known ones are, you know, in our temples-

Mm.

Yep, there'll, there'll be people who, who very quickly notice that they, they start to regain weight.

Then there'll be others who ma- are able to maintain for a period of maybe months to years, but slowly, slowly their own genetic hardwiring, their hor- their hormonal disbalance then sort of starts to recur.

And with that, I'll pass over to Dr. Ryan to get the presentation started.

Thank you very much, Campbell, and thank you to Healthcert and to La Roche-Posay for inviting me to discuss a topic that's very close to my heart, which is management of acne.

Tonight, this presentation really is going to focus on the role of dermocosmetic skincare as both monotherapy and adjunctive therapy in the treatment of acne.

We'll spend the majority of time understanding where skincare really plays a role in the management of acne.

Obviously, there's a huge amount of information out there.

There are so many different brands available between what people can find in pharmacies, online and through social media.

So I think it is really incumbent on us as healthcare professionals to have the latest evidence basis.

of the female's life, for example,